Clinical Presentation and Management of Pulmonary Infection Caused by Mycobacterium paraffinicum
Abstract
Non-tuberculous mycobacteria (NTM) are environmental organisms that rarely cause infections in healthy individuals but can be opportunistic pathogens in those with compromised immune systems or chronic lung conditions. Mycobacterium paraffinicum, a newly recognized species, is among these rare pathogens. We report a rare case of pulmonary infection with M. paraffinicum, detailing its clinical presentation, investigative findings, and treatment outcome. A 50-year-old male smoker with a history of chronic obstructive pulmonary disease (COPD), severe emphysema, and other comorbidities presented with chronic cough, progressive shortness of breath, and weight loss. Initial clinical suspicion focused on pulmonary tuberculosis (TB) due to his symptoms and family history, but sputum smear microscopy and subsequent biopsy revealed M. paraffinicum. This diagnosis was confirmed by culture showing sensitivity to clarithromycin and amikacin and intermediate sensitivity to moxifloxacin. Investigations included chest X-ray and high-resolution computed tomography (HRCT), which revealed a large left apical cavity, progressive nodular wall thickening, and bilateral inflammatory nodules. The patient was initially managed as TB, but virology and serology screens were negative for common pathogens, including TB. The pivotal biopsy identified the NTM infection, leading to a revised diagnosis. Treatment was managed by a multidisciplinary team and included a regimen of rifampicin, ethambutol,…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.